Partner Fund Management
Latest statistics and disclosures from PFM Health Sciences's latest quarterly 13F-HR filing:
- Top 5 stock holdings are THC, LLY, AXSM, CNC, PEN, and represent 28.78% of PFM Health Sciences's stock portfolio.
- Added to shares of these 10 stocks: GKOS (+$23M), CNC (+$22M), TMO (+$21M), MDT (+$21M), SYK (+$18M), UNH (+$17M), DXCM (+$15M), NBIX (+$15M), AMRX (+$14M), CAH (+$13M).
- Started 30 new stock positions in JAZZ, DXCM, BTSG, SYK, CAH, FTRE, NPCE, TMCI, SNY, CGEM.
- Reduced shares in these 10 stocks: LLY (-$169M), , , AXSM (-$51M), ISRG (-$35M), HUM (-$30M), , HCA (-$24M), VERA (-$21M), ELV (-$20M).
- Sold out of its positions in AKRO, COR, ELV, ARQT, AstraZeneca, BSX, ELVN, HIMS, HUM, IRTC. IWM, LQDA, MCK, MNMD, NTRA, REGN, SPY, XBI, TEVA, VRNA, HOWL, WST, MRUS.
- PFM Health Sciences was a net seller of stock by $-504M.
- PFM Health Sciences has $1.0B in assets under management (AUM), dropping by -22.88%.
- Central Index Key (CIK): 0001442756
Tip: Access up to 7 years of quarterly data
Positions held by Partner Fund Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for PFM Health Sciences
PFM Health Sciences holds 77 positions in its portfolio as reported in the December 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Tenet Healthcare Corp Com New (THC) | 7.9 | $79M | -13% | 398k | 198.72 |
|
| Eli Lilly & Co. (LLY) | 7.3 | $73M | -69% | 68k | 1074.68 |
|
| Axsome Therapeutics (AXSM) | 4.6 | $46M | -52% | 252k | 182.64 |
|
| Centene Corporation (CNC) | 4.5 | $45M | +91% | 1.1M | 41.15 |
|
| Penumbra (PEN) | 4.5 | $45M | -25% | 145k | 310.91 |
|
| Ascendis Pharma A/s Sponsored Adr (ASND) | 3.8 | $38M | +22% | 178k | 213.24 |
|
| United Therapeutics Corporation (UTHR) | 3.3 | $33M | -29% | 68k | 487.25 |
|
| Bridgebio Pharma (BBIO) | 2.3 | $23M | -6% | 307k | 76.49 |
|
| Adma Biologics (ADMA) | 2.3 | $23M | +7% | 1.3M | 18.24 |
|
| Neurocrine Biosciences (NBIX) | 2.3 | $23M | +185% | 163k | 141.83 |
|
| Glaukos (GKOS) | 2.3 | $23M | NEW | 202k | 112.91 |
|
| Thermo Fisher Scientific (TMO) | 2.2 | $22M | +1538% | 38k | 579.45 |
|
| Edwards Lifesciences (EW) | 2.1 | $21M | -35% | 247k | 85.25 |
|
| Icon SHS (ICLR) | 2.1 | $21M | -13% | 115k | 182.22 |
|
| Inhibrx Biosciences (INBX) | 2.1 | $21M | +10% | 266k | 79.00 |
|
| Medtronic SHS (MDT) | 2.0 | $21M | NEW | 214k | 96.06 |
|
| Neogenomics Com New (NEO) | 2.0 | $20M | -23% | 1.7M | 11.76 |
|
| Merck & Co (MRK) | 2.0 | $20M | -20% | 188k | 105.26 |
|
| Amneal Pharmaceuticals Com Stk Cl A (AMRX) | 1.8 | $19M | +311% | 1.5M | 12.60 |
|
| Stryker Corporation (SYK) | 1.8 | $18M | NEW | 51k | 351.47 |
|
| UnitedHealth (UNH) | 1.7 | $17M | NEW | 51k | 330.11 |
|
| Waters Corporation (WAT) | 1.6 | $16M | +40% | 43k | 379.83 |
|
| Ascendis Pharma A/s Note 2.250% 4/0 (Principal) | 1.5 | $15M | -7% | 11M | 1.42 |
|
| Dex (DXCM) | 1.5 | $15M | NEW | 227k | 66.37 |
|
| Centessa Pharmaceuticals Sponsored Ads (CNTA) | 1.5 | $15M | -11% | 592k | 25.01 |
|
| Indivior Ord | 1.3 | $13M | -35% | 361k | 35.88 |
|
| Cardinal Health (CAH) | 1.3 | $13M | NEW | 62k | 205.50 |
|
| Universal Hlth Svcs CL B (UHS) | 1.2 | $13M | -50% | 57k | 218.02 |
|
| Teleflex Incorporated (TFX) | 1.2 | $13M | NEW | 102k | 122.04 |
|
| Revolution Medicines (RVMD) | 1.2 | $12M | -54% | 152k | 79.65 |
|
| Soleno Therapeutics (SLNO) | 1.1 | $12M | 248k | 46.30 |
|
|
| Praxis Precision Medicines I Com New (PRAX) | 0.9 | $9.2M | -48% | 31k | 294.74 |
|
| Intuitive Surgical Com New (ISRG) | 0.9 | $8.7M | -80% | 15k | 566.36 |
|
| Gilead Sciences (GILD) | 0.9 | $8.7M | NEW | 71k | 122.74 |
|
| Jazz Pharmaceuticals Shs Usd (JAZZ) | 0.9 | $8.6M | NEW | 51k | 170.00 |
|
| CVS Caremark Corporation (CVS) | 0.9 | $8.6M | -68% | 108k | 79.36 |
|
| Sanofi Sa Sponsored Adr (SNY) | 0.9 | $8.5M | NEW | 176k | 48.46 |
|
| Iqvia Holdings (IQV) | 0.9 | $8.5M | NEW | 38k | 225.41 |
|
| Integer Hldgs (ITGR) | 0.8 | $8.4M | NEW | 107k | 78.43 |
|
| Cooper Cos (COO) | 0.8 | $8.3M | +35% | 101k | 81.96 |
|
| Veeva Sys Cl A Com (VEEV) | 0.7 | $7.3M | -21% | 33k | 223.23 |
|
| Oscar Health Cl A (OSCR) | 0.7 | $7.2M | -39% | 500k | 14.37 |
|
| Billiontoone Cl A (BLLN) | 0.7 | $7.2M | NEW | 88k | 81.84 |
|
| Cg Oncology (CGON) | 0.7 | $6.8M | +3% | 164k | 41.52 |
|
| Viking Therapeutics (VKTX) | 0.7 | $6.6M | +2% | 189k | 35.18 |
|
| Align Technology (ALGN) | 0.7 | $6.6M | NEW | 42k | 156.15 |
|
| Hca Holdings (HCA) | 0.6 | $6.5M | -78% | 14k | 466.86 |
|
| Personalis Ord (PSNL) | 0.6 | $6.4M | NEW | 806k | 7.96 |
|
| Vera Therapeutics Cl A (VERA) | 0.5 | $5.5M | -79% | 108k | 50.64 |
|
| Compass Pathways Sponsored Ads (CMPS) | 0.5 | $5.4M | -53% | 780k | 6.90 |
|
| Syndax Pharmaceuticals (SNDX) | 0.5 | $5.1M | -5% | 243k | 21.01 |
|
| Structure Therapeutics Sponsored Ads (GPCR) | 0.5 | $4.7M | -40% | 68k | 69.55 |
|
| Elanco Animal Health (ELAN) | 0.5 | $4.7M | NEW | 207k | 22.63 |
|
| Brightspring Health Svcs (BTSG) | 0.4 | $4.4M | NEW | 119k | 37.45 |
|
| Rhythm Pharmaceuticals (RYTM) | 0.4 | $4.3M | -16% | 40k | 107.04 |
|
| Abivax Sa Sponsored Ads (ABVX) | 0.4 | $4.3M | NEW | 32k | 134.85 |
|
| Madrigal Pharmaceuticals (MDGL) | 0.4 | $4.2M | NEW | 7.3k | 582.34 |
|
| Dianthus Therapeutics (DNTH) | 0.4 | $4.1M | +46% | 100k | 41.21 |
|
| Molina Healthcare (MOH) | 0.4 | $4.0M | NEW | 23k | 173.54 |
|
| Celldex Therapeutics Com New (CLDX) | 0.4 | $3.6M | NEW | 133k | 27.16 |
|
| Medline Com Cl A (MDLN) | 0.4 | $3.6M | NEW | 85k | 42.00 |
|
| Argenx Se Sponsored Adr (ARGX) | 0.4 | $3.5M | -34% | 4.2k | 840.95 |
|
| Belite Bio Sponsored Ads (BLTE) | 0.3 | $3.2M | NEW | 20k | 159.96 |
|
| Fortrea Hldgs Common Stock (FTRE) | 0.3 | $2.9M | NEW | 165k | 17.25 |
|
| Mbx Biosciences (MBX) | 0.2 | $2.5M | -64% | 79k | 31.54 |
|
| Cullinan Oncology (CGEM) | 0.2 | $2.3M | NEW | 227k | 10.35 |
|
| Tarsus Pharmaceuticals (TARS) | 0.2 | $2.2M | NEW | 27k | 81.88 |
|
| Outset Med Com New (OM) | 0.2 | $2.0M | -69% | 531k | 3.71 |
|
| Mineralys Therapeutics (MLYS) | 0.2 | $1.7M | NEW | 48k | 36.29 |
|
| Amylyx Pharmaceuticals (AMLX) | 0.2 | $1.6M | -69% | 135k | 12.08 |
|
| Caribou Biosciences (CRBU) | 0.2 | $1.5M | -29% | 958k | 1.59 |
|
| Uniqure Nv SHS (QURE) | 0.1 | $945k | -14% | 40k | 23.93 |
|
| Tectonic Therapeutic (TECX) | 0.1 | $891k | NEW | 43k | 20.86 |
|
| Disc Medicine (IRON) | 0.1 | $874k | -66% | 11k | 79.41 |
|
| Rezolute Com New (RZLT) | 0.0 | $487k | -54% | 206k | 2.36 |
|
| Neuropace (NPCE) | 0.0 | $175k | NEW | 11k | 15.44 |
|
| Treace Med Concepts (TMCI) | 0.0 | $123k | NEW | 50k | 2.45 |
|
Past Filings by PFM Health Sciences
SEC 13F filings are viewable for PFM Health Sciences going back to 2010
- PFM Health Sciences 2025 Q4 filed Feb. 17, 2026
- PFM Health Sciences 2025 Q3 filed Nov. 14, 2025
- PFM Health Sciences 2025 Q2 filed Aug. 14, 2025
- PFM Health Sciences 2025 Q1 filed May 15, 2025
- PFM Health Sciences 2024 Q4 filed Feb. 14, 2025
- PFM Health Sciences 2024 Q3 filed Nov. 14, 2024
- PFM Health Sciences 2024 Q2 filed Aug. 14, 2024
- PFM Health Sciences 2024 Q1 filed May 14, 2024
- PFM Health Sciences 2023 Q4 filed Feb. 14, 2024
- PFM Health Sciences 2023 Q3 filed Nov. 14, 2023
- PFM Health Sciences 2023 Q2 filed Aug. 14, 2023
- PFM Health Sciences 2023 Q1 filed May 15, 2023
- PFM Health Sciences 2022 Q4 filed Feb. 14, 2023
- PFM Health Sciences 2022 Q3 filed Nov. 14, 2022
- PFM Health Sciences 2022 Q2 filed Aug. 15, 2022
- PFM Health Sciences 2022 Q1 filed May 16, 2022